| FAT4 altered in cohorts of …ALTERED_INderived24 of 24show fewer |
|---|
| → altered in cohorts of | Skin Basal Cell Carcinoma 57 / 126 cases (45 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Squamous Cell Carcinoma 35 / 83 cases (42 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 148 / 469 cases (32 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| → altered in cohorts of | Melanoma 43 / 144 cases (30 %) · ssm · mel_dfci_2019 · largest of 2 cohorts | — | — | Melanoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 99 / 429 cases (23 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 108 / 517 cases (21 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 99 / 518 cases (19 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 85 / 478 cases (18 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Rectal Adenocarcinoma 25 / 155 cases (16 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 39 / 247 cases (16 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 86 / 566 cases (15 %) · ssm · luad_tcga_pan_can_atlas_2018 · largest of 7 cohorts | — | — | Lung Adenocarcinoma | 7 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 24 / 158 cases (15 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Large B-Cell Lymphoma Unclassifiable 20 / 135 cases (15 %) · ssm · dlbcl_dfci_2018 | — | — | Diffuse Large B-Cell Lymphoma Unclassifiable | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 25 / 185 cases (14 %) · ssm · esca_tcga · largest of 2 cohorts | — | — | Esophageal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 65 / 484 cases (13 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 153 / 1,144 cases (13 %) · ssm · nsclc_tcga_broad_2016 · largest of 2 cohorts | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 37 / 297 cases (12 %) · ssm · mbn_sfu_2023 | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 112 / 1,015 cases (11 %) · ssm · crc_sysucc_2022 · largest of 5 cohorts | — | — | Colorectal Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 52 / 474 cases (11 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Multiple Myeloma 84 / 961 cases (8.7 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 41 / 515 cases (8.0 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 31 / 494 cases (6.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Prostate Adenocarcinoma 24 / 444 cases (5.4 %) · ssm · prad_su2c_2019 | — | — | Prostate Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 23 / 444 cases (5.2 %) · ssm · difg_glass_2019 | — | — | Diffuse Glioma | 1 | Observed | cbioportal | graph → |